| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |